Chemical and Pharmaceutical Bulletin p. 2042 - 2048 (1994)
Update date:2022-09-26
Topics:
Ohno
Koumori
Adachi
Mizukoshi
Nagasaka
Ichihara
A series of new (5R,8S,10R)-ergoline derivatives was synthesized, and their antihypertensive and dopaminergic activities were evaluated in conscious spontaneously hypertensive rats and in rats with unilateral 6-hydroxydopamine-induced lesions of the substantia nigra, respectively. (5R,8S,10R)-6-Methyl-8-ergolinemethanols, prepared from the corresponding ergolinecarboxylates, were converted to the tosylates, which were treated with various five-membered heterocycles containing nitrogen atoms to afford the new ergolines. (5R,8S,10R)-8-(1-Imidazolylmethyl)-6-methylergoline (5a, BAM-2101) and (5R,8S,10R)-2-bromo-6-methyl-8-(1,2,4-triazol-1-ylmethyl)ergoline (7c, BAM-2202) exhibited potent antihypertensive activities. The maximum falls of systolic blood presure after oral administration of 5a and 7c at 3 mg/kg were 95 and 132 mmHg, respectively, while those of cianergoline, bromocriptine mesylate, hydralazine, and nifedipine at the same dose were 40, 37, 47, and 49 mmHg, respectively. The durations of significant antihypertensive effects of these compounds except nifedipine were more than 7 h. None of the ergolines exhibited potent dopaminergic activity. Structure-activity relationships are discussed.
View Morewebsite:http://www.finetechnology-ind.com
Contact:86-27-87465837
Address:wuhan
SHANGHAI RORY FINE CHEMICALS CO.,LTD
Contact:0086-21-50702305/50343389
Address:Pudong Avenue 3040 building 2 room 103/50343389
Nanjing HuiBaiShi Biotechnology Co.,Ltd.
Contact:+86 (25)58745219
Address:No.606 Ningliu Road,LiuHe District.
shijiazhuang alkay chemicals co..ltd
Contact:86-311-67692035
Address:2601,juntang building,qiaodong district,shijiazhuang
Contact:+86-10-67147360/67107388
Address:No.18 Guangming Zhongjie, Chongwen District, Beijing, 100061, China
Doi:10.1016/S0040-4039(00)98584-8
(1985)Doi:10.1002/ejic.201900110
(2019)Doi:10.1016/S0040-4039(00)98115-2
(1985)Doi:10.1021/jo991328h
(2000)Doi:10.1002/jccs.200500086
(2005)Doi:10.1002/ejic.201500489
(2015)